Pittenger & Anderson Inc Novo Cure LTD Transaction History

Pittenger & Anderson Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$67.99 - $89.57 $951 - $1,253	14 Added 23.33%	74 $6,000
Q4 2021 Feb 10, 2022	BUY	$75.08 - $121.99 $1,426 - $2,317	19 Added 46.34%	60 $5,000
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $697 - $1,167	6 Added 17.14%	41 $5,000
Q2 2021 Aug 13, 2021	BUY	$130.4 - $225.58 $1,304 - $2,255	10 Added 40.0%	35 $8,000
Q3 2020 Nov 10, 2020	BUY	$58.05 - $111.31 $348 - $667	6 Added 31.58%	25 $3,000
Q1 2020 Apr 30, 2020	BUY	$57.05 - $95.75 $456 - $766	8 Added 72.73%	19 $1,000
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $680 - $1,075	11 New	11 $1,000

289

75.6M

1.77M

538K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.29B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

Stay updated on Pittenger & Anderson Inc with notifications on news.